JP2009503094A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009503094A5 JP2009503094A5 JP2008525134A JP2008525134A JP2009503094A5 JP 2009503094 A5 JP2009503094 A5 JP 2009503094A5 JP 2008525134 A JP2008525134 A JP 2008525134A JP 2008525134 A JP2008525134 A JP 2008525134A JP 2009503094 A5 JP2009503094 A5 JP 2009503094A5
- Authority
- JP
- Japan
- Prior art keywords
- mmhg
- blood pressure
- substituted
- compound
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 *C1=C(*)S=C(*)*1 Chemical compound *C1=C(*)S=C(*)*1 0.000 description 3
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US70563505P | 2005-08-03 | 2005-08-03 | |
| US60/705,635 | 2005-08-03 | ||
| PCT/US2006/030023 WO2007019153A2 (en) | 2005-08-03 | 2006-08-02 | Methods for treating hypertension |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009503094A JP2009503094A (ja) | 2009-01-29 |
| JP2009503094A5 true JP2009503094A5 (https=) | 2009-07-02 |
| JP5242393B2 JP5242393B2 (ja) | 2013-07-24 |
Family
ID=37727864
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008525134A Expired - Fee Related JP5242393B2 (ja) | 2005-08-03 | 2006-08-02 | 高血圧症の治療方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US20070167454A1 (https=) |
| EP (1) | EP1940397A4 (https=) |
| JP (1) | JP5242393B2 (https=) |
| CA (1) | CA2617248C (https=) |
| WO (1) | WO2007019153A2 (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2607953A1 (en) | 2005-05-09 | 2006-11-16 | Tap Pharmaceutical Products, Inc. | Methods for treating nephrolithiasis |
| US20090124623A1 (en) * | 2006-11-13 | 2009-05-14 | Christopher Lademacher | Methods for preserving and/or increasing renal function using xanthine oxidoreductase inhibitors |
| EP2101761A4 (en) * | 2006-11-13 | 2010-01-27 | Takeda Pharmaceuticals North A | METHODS FOR PRESERVING RENAL FUNCTION USING XANTHINE OXYDOREDUCTASE INHIBITORS |
| CN101646440A (zh) * | 2007-01-19 | 2010-02-10 | 武田制药北美公司 | 使用黄嘌呤氧化还原酶抑制剂和抗炎剂预防痛风突发或减少痛风突发次数的方法 |
| WO2008126772A1 (ja) * | 2007-04-05 | 2008-10-23 | Astellas Pharma Inc. | 高血圧治療剤 |
| US20100311756A1 (en) * | 2009-01-22 | 2010-12-09 | Takeda Pharmaceuticals North America, Inc. | Methods for delaying the progression of at least one of cardiac hypertrophy, cardiac remodeling or left ventricular function or the onset of heart failure in subjects in need of treatment thereof |
| JP5753082B2 (ja) * | 2009-06-26 | 2015-07-22 | 帝人ファーマ株式会社 | 高血圧症または正常高値血圧症の治療薬 |
| IT1400310B1 (it) | 2010-05-10 | 2013-05-24 | Menarini Int Operations Lu Sa | Associazione di inibitori della xantina ossidasi e statine e loro uso. |
| IT1400311B1 (it) | 2010-05-10 | 2013-05-24 | Menarini Int Operations Lu Sa | Associazione di inibitori della xantina ossidasi e antagonisti del recettore dell'angiotensina ii e loro uso. |
| IT1400309B1 (it) | 2010-05-10 | 2013-05-24 | Menarini Int Operations Lu Sa | Associazione di inibitori della xantina ossidasi e calcio antagonisti e loro uso. |
| IT1400609B1 (it) | 2010-05-10 | 2013-06-14 | Menarini Int Operations Lu Sa | Associazione di inibitori della xantina ossidasi e metformina e loro uso. |
| WO2011162390A1 (ja) * | 2010-06-25 | 2011-12-29 | 帝人ファーマ株式会社 | 徐放性高血圧および腎機能障害治療剤 |
| AU2011299153B2 (en) * | 2010-09-10 | 2014-10-30 | Takeda Pharmaceuticals U.S.A., Inc. | Methods for concomitant treatment of theophylline and febuxostat |
| RU2014134845A (ru) | 2012-01-27 | 2016-03-20 | Тейдзин Фарма Лимитед | Терапевтическое средство против диабета |
| EP3417858B8 (en) | 2016-02-19 | 2020-12-30 | National University Corporation Tottori University | Therapeutic or prophylactic drug for dementia |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4058614A (en) * | 1973-12-04 | 1977-11-15 | Merck & Co., Inc. | Substituted imidazole compounds and therapeutic compositions therewith |
| US4296122A (en) * | 1975-07-09 | 1981-10-20 | Merck & Co., Inc. | 2,3-Dihydro-6,7-disubstituted-5-(acyl)benzofuran-2-carboxylic acids |
| DE2727802A1 (de) * | 1977-06-21 | 1979-04-19 | Hoechst Ag | Sulfamoyl-arylketone und verfahren zu ihrer herstellung |
| US4510322A (en) * | 1981-07-13 | 1985-04-09 | Merck & Co., Inc. | Indacrinone having enhanced uricosuric |
| US4632930A (en) * | 1984-11-30 | 1986-12-30 | E. I. Du Pont De Nemours And Company | Antihypertensive alkyl-arylimidazole, thiazole and oxazole derivatives |
| JPH0366669A (ja) * | 1989-08-03 | 1991-03-22 | Shionogi & Co Ltd | 複素環式化合物 |
| ES2092580T3 (es) * | 1990-11-30 | 1996-12-01 | Teijin Ltd | Derivado de 2-ariltiazol y composicion farmaceutica que contiene el mismo. |
| US5358961A (en) * | 1991-11-30 | 1994-10-25 | Jin Ro Limited | Pyrrolidine derivatives |
| SE9301830D0 (sv) * | 1993-05-28 | 1993-05-28 | Ab Astra | New compounds |
| ID21775A (id) * | 1996-10-25 | 1999-07-22 | Yoshitomi Pharmaceutical | Senyawa-senyawa 1-fenilpirazol dan penggunaan farmasinya |
| GB9824310D0 (en) * | 1998-11-05 | 1998-12-30 | Univ London | Activators of soluble guanylate cyclase |
| US6281222B1 (en) * | 1999-08-19 | 2001-08-28 | Inotek Corporation | Compositions and method for treatment of acetaminophen intoxication |
| EP1317258B1 (en) * | 2000-06-28 | 2009-02-11 | Merck & Co., Inc. | Use of allopurinol for the treatment of hypertension |
| JP2005507932A (ja) * | 2001-10-12 | 2005-03-24 | バイエル・フアーマシユーチカルズ・コーポレーシヨン | 肥満の処置のためのフェニル置換５−員窒素含有複素環 |
| CA2462132C (en) * | 2002-01-28 | 2010-08-10 | Fuji Yakuhin Co., Ltd. | 1,2,4-triazole compounds |
| US20060040945A1 (en) * | 2002-05-17 | 2006-02-23 | Merckle Gmbh | Annellated pyrrole compounds as proton pump inhibitors for treating ulcer |
| US20040131676A1 (en) * | 2002-12-20 | 2004-07-08 | Rajneesh Taneja | Dosage forms containing a PPI, NSAID, and buffer |
| US20040121004A1 (en) * | 2002-12-20 | 2004-06-24 | Rajneesh Taneja | Dosage forms containing a PPI, NSAID, and buffer |
| WO2005018635A2 (en) * | 2003-08-07 | 2005-03-03 | Cardiome Pharma Corp. | Ion channel modulating activity i |
| CA2607953A1 (en) * | 2005-05-09 | 2006-11-16 | Tap Pharmaceutical Products, Inc. | Methods for treating nephrolithiasis |
| EP2101761A4 (en) * | 2006-11-13 | 2010-01-27 | Takeda Pharmaceuticals North A | METHODS FOR PRESERVING RENAL FUNCTION USING XANTHINE OXYDOREDUCTASE INHIBITORS |
| US20090124623A1 (en) * | 2006-11-13 | 2009-05-14 | Christopher Lademacher | Methods for preserving and/or increasing renal function using xanthine oxidoreductase inhibitors |
| CN101646440A (zh) * | 2007-01-19 | 2010-02-10 | 武田制药北美公司 | 使用黄嘌呤氧化还原酶抑制剂和抗炎剂预防痛风突发或减少痛风突发次数的方法 |
| US20100311756A1 (en) * | 2009-01-22 | 2010-12-09 | Takeda Pharmaceuticals North America, Inc. | Methods for delaying the progression of at least one of cardiac hypertrophy, cardiac remodeling or left ventricular function or the onset of heart failure in subjects in need of treatment thereof |
| AU2011299153B2 (en) * | 2010-09-10 | 2014-10-30 | Takeda Pharmaceuticals U.S.A., Inc. | Methods for concomitant treatment of theophylline and febuxostat |
-
2006
- 2006-08-02 EP EP06774718A patent/EP1940397A4/en not_active Withdrawn
- 2006-08-02 JP JP2008525134A patent/JP5242393B2/ja not_active Expired - Fee Related
- 2006-08-02 CA CA2617248A patent/CA2617248C/en not_active Expired - Fee Related
- 2006-08-02 WO PCT/US2006/030023 patent/WO2007019153A2/en not_active Ceased
- 2006-08-02 US US11/497,608 patent/US20070167454A1/en not_active Abandoned
-
2014
- 2014-04-07 US US14/246,551 patent/US20140329868A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010509372A5 (https=) | ||
| JP2009503094A5 (https=) | ||
| RU2436780C2 (ru) | Производные 5-фенилтиазола и их применение в качестве ингибиторов рi3 киназы | |
| RU2439068C2 (ru) | Модуляторы mglur5 | |
| RU2009122505A (ru) | Способы сохранения функции почек с использованием ингибиторов ксантин оксидоредуктазы | |
| JP2011507868A5 (https=) | ||
| JP2004517087A5 (https=) | ||
| JP2013539747A5 (https=) | ||
| JP2017523972A5 (https=) | ||
| JP2008513515A5 (https=) | ||
| JP2007523182A5 (https=) | ||
| JP2010515715A5 (https=) | ||
| JP2004517080A5 (https=) | ||
| JP2010513319A5 (https=) | ||
| JP2014532070A5 (https=) | ||
| CA2710409A1 (en) | 6h-dibenz0 [b,e] oxepine derived nonsteroidal mineralocorticoid receptor antagonists | |
| JP2010530431A5 (https=) | ||
| JP2006513202A5 (https=) | ||
| WO2012048181A4 (en) | Novel substituted quinoline compounds as s-nitrosoglutathione reductase inhibitors | |
| JP2002534519A5 (https=) | ||
| RU2013138569A (ru) | Антагонисты рецептора минералокортикоидов | |
| JP2004520292A5 (https=) | ||
| RU2013109380A (ru) | Способ сопутствующей терапии с применением теофиллина и фебуксостата | |
| JP2007527919A5 (https=) | ||
| RU2012116877A (ru) | Соединения 2-пиридона, применяемые в качестве ингибиторов нейтрофильной эластазы |